User profiles for A. Onar-Thomas

Arzu Onar-Thomas

Professor of Biostatistics, St Jude Children's Research Hospital
Verified email at stjude.org
Cited by 10905

Novel mutations target distinct subgroups of medulloblastoma

…, J Ma, J Easton, B Vadodaria, A Onar-Thomas… - Nature, 2012 - nature.com
Medulloblastoma is a malignant childhood brain tumour comprising four discrete subgroups.
Here, to identify mutations that drive medulloblastoma, we sequenced the entire genomes …

[HTML][HTML] Vismodegib exerts targeted efficacy against recurrent sonic hedgehog–subgroup medulloblastoma: results from phase II pediatric brain tumor consortium …

…, M Rusch, SJ Allen, A Onar-Thomas… - Journal of Clinical …, 2015 - ncbi.nlm.nih.gov
… Allen, Arzu Onar-Thomas, Clinton F. Stewart, Maryam Fouladi, James M. Boyett, David W. …
Allen, Arzu Onar-Thomas, James M. Boyett, Richard J. Gilbertson, Tom Curran, David W …

[HTML][HTML] Genome-wide analyses identify recurrent amplifications of receptor tyrosine kinases and cell-cycle regulatory genes in diffuse intrinsic pontine glioma

…, SN Chi, NS da Silva, A Onar-Thomas… - Journal of clinical …, 2011 - ncbi.nlm.nih.gov
Purpose Long-term survival for children with diffuse intrinsic pontine glioma (DIPG) is less
than 10%, and new therapeutic targets are urgently required. We evaluated a large cohort of …

Selumetinib in paediatric patients with BRAF-aberrant or neurofibromatosis type 1-associated recurrent, refractory, or progressive low-grade glioma: a multicentre …

J Fangusaro, A Onar-Thomas, TY Poussaint… - The lancet …, 2019 - thelancet.com
Background Paediatric low-grade glioma is the most common CNS tumour of childhood.
Although overall survival is good, disease often recurs. No single universally accepted …

[HTML][HTML] Processing speed, attention, and working memory after treatment for medulloblastoma: an international, prospective, and longitudinal study

SL Palmer, C Armstrong, A Onar-Thomas… - Journal of Clinical …, 2013 - ncbi.nlm.nih.gov
… Palmer, Carol Armstrong, Arzu Onar-Thomas, Shengjie Wu, Dana Wallace, Melanie J.
Bonner, Jane Schreiber, Michelle Swain, Lynn Chapieski, Donald Mabbott, Sarah Knight …

[HTML][HTML] Outcomes by clinical and molecular features in children with medulloblastoma treated with risk-adapted therapy: results of an international phase III trial …

…, SM Pfister, RJ Gilbertson, A Onar-Thomas… - Journal of Clinical …, 2021 - ncbi.nlm.nih.gov
RESULTS Three hundred thirty eligible patients with medulloblastoma were enrolled. Five-year
PFS was 83.2%(95% CI, 78.4 to 88.2) for average-risk patients (n= 227) and 58.7%(95% …

Unified rhombic lip origins of group 3 and group 4 medulloblastoma

…, J Golser, K Mankad, H Sheppard, A Onar-Thomas… - Nature, 2022 - nature.com
Medulloblastoma, a malignant childhood cerebellar tumour, segregates molecularly into
biologically distinct subgroups, suggesting that a personalized approach to therapy would be …

Novel Oncogenic PDGFRA Mutations in Pediatric High-Grade Gliomas

…, DA Bax, D Carvalho, RM Reis, A Onar-Thomas… - Cancer research, 2013 - AACR
The outcome for children with high-grade gliomas (HGG) remains dismal, with a 2-year
survival rate of only 10% to 30%. Diffuse intrinsic pontine glioma (DIPG) comprise a subset of …

[PDF][PDF] Histone H3. 3 K27M accelerates spontaneous brainstem glioma and drives restricted changes in bivalent gene expression

…, B Xu, T Lin, CL Tinkle, Z Patay, A Onar-Thomas… - Cancer cell, 2019 - cell.com
Diffuse intrinsic pontine gliomas (DIPGs) are incurable childhood brainstem tumors with
frequent histone H3 K27M mutations and recurrent alterations in PDGFRA and TP53. We …

[PDF][PDF] Serial assessment of measurable residual disease in medulloblastoma liquid biopsies

…, BA Orr, DW Ellison, RJ Gilbertson, A Onar-Thomas… - Cancer cell, 2021 - cell.com
Nearly one-third of children with medulloblastoma, a malignant embryonal tumor of the
cerebellum, succumb to their disease. Conventional response monitoring by imaging and …